Large Vessel Occlusion Strokes After the DIRECT-MT and SKIP Trials: Is the Alteplase Syringe Half Empty or Half Full?

Raul G Nogueira¹, Georgios Tsivgoulis^{2

3}

Affiliations

¹ Department of Neurology, Emory University School of Medicine, Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Atlanta, GA (R.G.N.).
² Second Department of Neurology, National and Kapodistrian University of Athens, Greece (G.T.).
³ Department of Neurology, University of Tennessee HealthCare Center, Memphis (G.T.).

Raul G Nogueira et al. Stroke. 2020 Oct.

. 2020 Oct;51(10):3182-3186.

doi: 10.1161/STROKEAHA.120.030796. Epub 2020 Sep 11.

Raul G Nogueira¹, Georgios Tsivgoulis^{2

3}

¹ Department of Neurology, Emory University School of Medicine, Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Atlanta, GA (R.G.N.).
² Second Department of Neurology, National and Kapodistrian University of Athens, Greece (G.T.).
³ Department of Neurology, University of Tennessee HealthCare Center, Memphis (G.T.).

No abstract available

Keywords: brain ischemia; intracranial hemorrhages; reperfusion; thrombolytic therapy; tissue-type plasminogen activator.

MeSH terms